Guidance slashed, court delays drag—brand intact but visibility zero

The Madhya Pradesh plant—Som's largest facility—has been court-ordered shut for 6 months. The closure is sub judice, meaning management cannot publicly disclose the timeline or specifics. The result: ₹250–260 Cr in quarterly revenue offline, and ₹6–7 Cr in fixed costs (salaries, interest, utilities) continuing on zero output. Additionally, ₹25 Cr in finished goods inventory is trapped in Bhopal with roughly 1 month of shelf life remaining. Everything else in the quarter—the margins, the profit collapse, the guidance cut—flows directly from this single operational failure.

It is crucial to separate what this means: the headline numbers are real and terrible, but they are entirely explained by one temporary (albeit opaque) event. Remove the MP disruption and the underlying business—regional recovery in Karnataka and Odisha, premiumization momentum, cash generation, the UP platform build—shows structural resilience. The market has seized on that gap and marked down the stock accordingly.

FY27 revenue guidance: Cut from ₹1,400–1,500 Cr (stated on FY26 calls) to ₹1,000–1,100 Cr (mid-quarter revision). The 28–32% downgrade reflects the MP closure extending longer than initially expected. MP restart timeline: On the prior call, management promised a restart within 15 days. Six months have now passed with no public update. The matter is sub judice, so the company cannot disclose specifics—but the prior commit has evaporated. Analysts pressed hard on this (Manoj Pal asked directly); management deflected and said it was 'hopeful' for August resolution with no guarantee. Andhra Pradesh entry: Originally promised for Q1 FY27; delayed to first week September 2026 due to state excise authority and corporate permission delays. UP ramp timeline: Management now expects 3–4 years to reach peak 10M case utilization at the UP facility (commissioned June 2026). This is slower than the implied ramp suggested on earlier calls.

Price action & market verdict: The result was announced on 2026-08-20 at a pre-result close of ₹73.52. Day 1 saw a -2.75% selloff (to roughly ₹71.50), which held steady through day 3 (+0.92%, recovery attempt) and day 5 (+0.65%, faded). The market's own verdict: the initial shock held; no re-rating upside materialized. The sell-off was measured but decisive, reflecting the street's refusal to buy the 'underlying strength' narrative without visibility into MP's restart.

Valuation & drawdown context: The stock now trades at ₹73.51, down 45% from its all-time high of ₹134.02. However, it is up 19% off its 52-week low of ₹61.8, and currently trades above both the 20-day and 50-day simple moving averages (₹72.74 and ₹71.96, respectively) but below the 200-day average of ₹88.18. RSI is neutral at 55.2. This suggests the stock is not yet oversold on a technicals basis, but momentum has decisively turned. If downside news emerges (further MP delay), the next major support is ₹61.8 (the 52-week low).

Institutional positioning (FII/DII exodus): This is the most telling market signal. Foreign institutions held 1.20% of Som in Q4 FY26 and have exited to just 0.18% in Q1 FY27—a collapse of 1.02 percentage points in a single quarter. Domestic institutions remain absent (0.00% DII holding). Promoters hold steady at 39.44%. Interpretation: Hot foreign capital is fleeing on execution risk (guidance miss, MP opacity, credibility hit). Domestic institutions are not catching the knife. Promoters are not buying the dip, suggesting either waning confidence or locked-in holdings. The FII exodus is the market's real statement: uncertainty on MP is not a short-term buy.